Your browser doesn't support javascript.
loading
Rationale for the administration of systemic 5-FU in combination with heated intraperitonal oxaliplatin.
Badrudin, D; Sideris, L; Leblond, F A; Pichette, V; Cloutier, A S; Drolet, P; Dubé, P.
Afiliação
  • Badrudin D; Maisonneuve-Rosemont Research Center, Maisonneuve-Rosemont Hospital, Université de Montréal, Montreal QC, Canada.
  • Sideris L; Maisonneuve-Rosemont Research Center, Maisonneuve-Rosemont Hospital, Université de Montréal, Montreal QC, Canada.
  • Leblond FA; Maisonneuve-Rosemont Research Center, Maisonneuve-Rosemont Hospital, Université de Montréal, Montreal QC, Canada.
  • Pichette V; Maisonneuve-Rosemont Research Center, Maisonneuve-Rosemont Hospital, Université de Montréal, Montreal QC, Canada.
  • Cloutier AS; Maisonneuve-Rosemont Research Center, Maisonneuve-Rosemont Hospital, Université de Montréal, Montreal QC, Canada.
  • Drolet P; Maisonneuve-Rosemont Research Center, Maisonneuve-Rosemont Hospital, Université de Montréal, Montreal QC, Canada.
  • Dubé P; Maisonneuve-Rosemont Research Center, Maisonneuve-Rosemont Hospital, Université de Montréal, Montreal QC, Canada. Electronic address: pierredube@videotron.qc.ca.
Surg Oncol ; 27(2): 275-279, 2018 Jun.
Article em En | MEDLINE | ID: mdl-29937182
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Peritônio / Fluoruracila Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Peritônio / Fluoruracila Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article